The effectiveness of pergolide and cabergoline as an adjunct to levodopa in Parkinson's disease

被引：0
作者：
Subutay-Oztekin, N [1 ]
Oztekin, F [1 ]
机构：
[1] SSK Ankara Hosp, Ankara, Turkey
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
[41]   Pergolide mesylate in Parkinson's disease treatment [J].
Pezzoli, G ;
Canesi, M ;
Pesenti, A ;
Mariani, CB .
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (45) :203-212
[42]   Cabergoline versus pergolide in levodopa-treated Parkinson's disease patients with nocturnal disabilities: A randomised, double-blind crossover trial to evaluate efficacy, tolerability, and quality of life [J].
Trenkwalder, C ;
Canelo, M ;
Forbes, A ;
Leroux, M ;
Chaudhuri, KR .
MOVEMENT DISORDERS, 2004, 19 :S267-S267
[43]   PERGOLIDE IN PARKINSON DISEASE [J].
LIEBERMAN, AN ;
GOLDSTEIN, M ;
GOPINATHAN, G ;
NEOPHYTIDES, A ;
LEIBOWITZ, M ;
WALKER, R ;
HIESIGER, E .
NEUROLOGY, 1982, 32 (04) :A182-A182
[44]   Effectiveness of cabergoline in early and advanced PD and comparision of the results with pergolide [J].
Yilmaz, O. ;
Subutay-Oztekin, N. ;
Oztekin, M. F. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 :219-219
[45]   Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa [J].
Schwarz, J ;
Scheidtmann, K ;
Trenkwalder, C .
EUROPEAN NEUROLOGY, 1997, 37 (04) :236-238
[46]   Efficacy of preladenant, a novel A2A antagonist, as an adjunct to levodopa for the treatment of Parkinson's disease [J].
Hauser, R. A. ;
Pourcher, E. ;
Micheli, F. ;
Mok, V. ;
Onofrj, M. ;
Huyck, S. B. ;
Wolski, K. ;
Cantillon, M. .
MOVEMENT DISORDERS, 2009, 24 :S265-S265
[47]   Spotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapy [J].
Annus, Adam ;
Vecsei, Laszlo .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :143-151
[48]   Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis [J].
Kano, Osamu ;
Tsuda, Hiroshi ;
Hayashi, Ayako ;
Arai, Masaki .
PARKINSONS DISEASE, 2022, 2022
[49]   A CROSSOVER, CONTROLLED-STUDY COMPARING PERGOLIDE WITH BROMOCRIPTINE AS AN ADJUNCT TO LEVODOPA FOR THE TREATMENT OF PARKINSONS-DISEASE [J].
PEZZOLI, G ;
MARTIGNONI, E ;
PACCHETTI, C ;
ANGELERI, V ;
LAMBERTI, P ;
MURATORIO, A ;
BONUCCELLI, U ;
DEMARI, M ;
FOSCHI, N ;
COSSUTTA, E ;
NICOLETTI, F ;
GIAMMONA, G ;
CANESI, M ;
SCARLATO, G ;
CARACENI, T ;
MOSCARELLI, E .
NEUROLOGY, 1995, 45 (03) :22-27
[50]   Cabergoline, a long-acting dopamine agonist, overcomes levodopa refractory nocturnal disabilities in Parkinson's disease [J].
Chaudhuri, KR ;
Agapito, C ;
Porter, MC ;
Mills, J ;
Clough, CG .
NEUROLOGY, 1999, 52 (06) :A263-A263
12345